메뉴 건너뛰기
Lung Cancer
Volumn 52, Issue 2, 2006, Pages 261-262
Thymic carcinoma with epidermal growth factor receptor gene mutations
Author keywords

[No Author keywords available]
Indexed keywords

CISPLATIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ETOPOSIDE; GEFITINIB; GEMCITABINE; NAVELBINE;
EID: 33646007685     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.01.009     Document Type: Letter
Times cited : (32)
References (4)
  • 1
    • 20244388126 scopus 로고    scopus 로고
    • Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence.
    • Mitsudomi T., Kosaka T., Endoh H., Horio Y., Hida T., Mori S., et al. Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence. J Clin Oncol 23 (2005) 2513-2520
    • (2005) J Clin Oncol , vol.23 , pp. 2513-2520
    • Mitsudomi, T.1    Kosaka, T.2    Endoh, H.3    Horio, Y.4    Hida, T.5    Mori, S.6
  • 2
    • 27244451321 scopus 로고    scopus 로고
    • Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer
    • Takano T., Ohe Y., Sakamoto H., Tsuta K., Matsuno Y., Tateishi U., et al. Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer. J Clin Oncol 23 (2005) 6829-6837
    • (2005) J Clin Oncol , vol.23 , pp. 6829-6837
    • Takano, T.1    Ohe, Y.2    Sakamoto, H.3    Tsuta, K.4    Matsuno, Y.5    Tateishi, U.6
  • 3
    • 0037674062 scopus 로고    scopus 로고
    • Phase II trial of ZD1839 in recurrent or metastatic squamous cell cancer of the head and neck
    • Cohen E.E., Rosen F., Stadler W.M., Recant W., Stenson K., Huo D., et al. Phase II trial of ZD1839 in recurrent or metastatic squamous cell cancer of the head and neck. J Clin Oncol 21 (2003) 1980-1987
    • (2003) J Clin Oncol , vol.21 , pp. 1980-1987
    • Cohen, E.E.1    Rosen, F.2    Stadler, W.M.3    Recant, W.4    Stenson, K.5    Huo, D.6
  • 4
    • 12744259892 scopus 로고    scopus 로고
    • Protein expression and gene amplification of epidermal growth factor receptor in thymomas
    • Ionescu D.N., Sasatomi E., Cieply K., Nola M., and Dacic S. Protein expression and gene amplification of epidermal growth factor receptor in thymomas. Cancer 103 (2005) 630-636
    • (2005) Cancer , vol.103 , pp. 630-636
    • Ionescu, D.N.1    Sasatomi, E.2    Cieply, K.3    Nola, M.4    Dacic, S.5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.